Glaukos (GKOS) Income from Continuing Operations (2014 - 2026)
Glaukos (GKOS) posted quarterly Income from Continuing Operations of 18421000.0 for Q2 2026, up 6.29% year-over-year from 17331239.98 in Q2 2025, and up 6.96% quarter-over-quarter from 19799000.0 in Q1 2026.
Glaukos (GKOS) Income from Continuing Operations (2014 - 2026) Analysis & Trends
Glaukos (GKOS) has reported Income from Continuing Operations for 13 consecutive years, with 18421000.0 the latest figure, recorded in Q2 2026.
- In Q2 2026, Income from Continuing Operations rose 6.29% year-over-year to 18421000.0; the TTM figure through Jun 2026 stood at 157514000.0 (down 147.36% YoY), while the FY2025 annual figure was 157097000.0, down 33.98% from the prior year.
- Income from Continuing Operations improved to 18421000.0 in Q2 2026 per GKOS's latest filing, from 19799000.0 in the prior quarter.
- Across five years, Income from Continuing Operations topped out at 5377000.0 in Q1 2022 and bottomed at 103063000.0 in Q4 2025.
- Historically, Income from Continuing Operations has averaged 29154222.22 across 5 years, with a median of 24504000.0 in 2022.
- Annual changes were most pronounced in 2022 — Income from Continuing Operations soared 132.65% — and 2025, when it plunged 2219.67%.
- Glaukos' Income from Continuing Operations stood at 34347000.0 in 2022, then soared by 64.44% to 12214000.0 in 2023, then jumped by 63.62% to 4443000.0 in 2024, then slumped by 2219.67% to 103063000.0 in 2025, then soared by 82.13% to 18421000.0 in 2026.
- Business Quant data shows GKOS's Income from Continuing Operations at 18421000.0 in Q2 2026, 19799000.0 in Q1 2026, and 103063000.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.95 Bn | 193.35 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Stryker | 128.10 Bn | 124.63 Bn | 4.50 Bn | 1.28 Bn |
| 3 | Medtronic | 118.91 Bn | 109.69 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 73.43 Bn | 72.89 Bn | 3.85 Bn | 905.00 Mn |
| 5 | Edwards Lifesciences | 51.91 Bn | 47.66 Bn | 1.35 Bn | 241.40 Mn |
| 6 | Dexcom | 34.52 Bn | 32.58 Bn | 830.00 Mn | 249.10 Mn |
| 7 | GE HealthCare Technologies | 33.94 Bn | 31.83 Bn | 2.18 Bn | 574.00 Mn |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | 1.04 Bn |
| 9 | Steris | 23.14 Bn | 22.66 Bn | 684.20 Mn | 201.00 Mn |
| 10 | Glaukos | 11.08 Bn | 10.96 Bn | 151.59 Mn | -18.42 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -18.42 Mn |
| Mar 31, 2026 | -19.80 Mn |
| Dec 31, 2025 | -103.06 Mn |
| Sep 30, 2025 | -16.23 Mn |
| Jun 30, 2025 | -19.66 Mn |
| Mar 31, 2025 | -18.15 Mn |
| Dec 31, 2024 | -4.44 Mn |
| Sep 30, 2024 | -21.43 Mn |
| Jun 30, 2024 | -50.55 Mn |
| Mar 31, 2024 | -40.86 Mn |
| Dec 31, 2023 | -12.21 Mn |
| Sep 30, 2023 | -30.44 Mn |
| Jun 30, 2023 | -32.81 Mn |
| Mar 31, 2023 | -34.63 Mn |
| Dec 31, 2022 | -34.35 Mn |
| Sep 30, 2022 | -27.58 Mn |
| Jun 30, 2022 | -45.54 Mn |
| Mar 31, 2022 | 5.38 Mn |
| Dec 31, 2021 | -23.98 Mn |
| Sep 30, 2021 | 6.23 Mn |